S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
LON:KCT

Kin and Carta (KCT) Share Forecast, Price & News

GBX 220.50
+4.50 (+2.08%)
(As of 05/20/2022 12:00 AM ET)
Add
Compare
Today's Range
216
226.50
50-Day Range
210.06
289
52-Week Range
176.50
359
Volume
538,758 shs
Average Volume
380,065 shs
Market Capitalization
£392.01 million
P/E Ratio
16.83
Dividend Yield
3.05%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive KCT News and Ratings via Email

Sign-up to receive the latest news and ratings for Kin and Carta and its competitors with MarketBeat's FREE daily newsletter.

Kin and Carta logo

About Kin and Carta

Kin and Carta plc provides technology, data, consultancy, and digital transformation services in the United Kingdom, the United States, and internationally. The company offers cloud and platforms, digital products, data and AI, managed, digital experiences, and strategy and innovation services. It serves financial services, retail and distribution, industrial and agriculture, transportation, healthcare, and public and other sectors. The company was formerly known as St Ives plc and changed its name to Kin and Carta plc in October 2018. Kin and Carta plc was incorporated in 1981 and is headquartered in London, the United Kingdom.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Business Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
1,367
Year Founded
N/A

Sales & Book Value

Annual Sales
£174.43 million
Cash Flow
GBX 4.38 per share
Book Value
GBX 64.80 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£392.01 million
Optionable
Not Optionable

Company Calendar

Last Earnings
3/11/2020
Today
5/21/2022

MarketRank

Overall MarketRank

1.87 out of 5 stars

Analyst Opinion: 3.5Community Rank: 5.0Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -













Kin and Carta (LON:KCT) Frequently Asked Questions

Is Kin and Carta a buy right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Kin and Carta in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Kin and Carta stock.
View analyst ratings for Kin and Carta
or view top-rated stocks.

How were Kin and Carta's earnings last quarter?

Kin and Carta plc (LON:KCT) posted its earnings results on Wednesday, March, 11th. The company reported $2.75 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.60 by $0.15.
View Kin and Carta's earnings history
.

What price target have analysts set for KCT?

4 analysts have issued 1 year price objectives for Kin and Carta's shares. Their forecasts range from GBX 295 to GBX 390. On average, they anticipate Kin and Carta's share price to reach GBX 356.25 in the next year. This suggests a possible upside of 61.6% from the stock's current price.
View analysts' price targets for Kin and Carta
or view top-rated stocks among Wall Street analysts.

Who are Kin and Carta's key executives?
Kin and Carta's management team includes the following people:
  • Mr. John Schwan, CEO & Exec. Director
  • Mr. Chris Kutsor, CFO & Director
  • Mr. Charlie Wrench, Interim Head of Communications (Age 61)
  • Mr. Matthew Froggatt, Group Managing Director of Incite
  • Ms. Kelly Manthey, Group Chief Exec. of Americas
  • Mr. David Tuck, Chief Exec. of Europe
  • Mr. Damian Coverdale, Chief Exec. Officer of Edit
  • Mr. Tom Holt, Chief Exec. Officer of Pragma
  • Mr. Daniel Fattal ACA, Company Sec.
  • Ms. Fiona Proudler, Chief Exec. Officer of AmazeRealise
What other stocks do shareholders of Kin and Carta own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kin and Carta investors own include Novavax (NVAX), OPKO Health (OPK), Enphase Energy (ENPH) and Co-Diagnostics (CODX).

What is Kin and Carta's stock symbol?

Kin and Carta trades on the London Stock Exchange (LON) under the ticker symbol "KCT."

How do I buy shares of Kin and Carta?

Shares of KCT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Kin and Carta's stock price today?

One share of KCT stock can currently be purchased for approximately GBX 220.50.

How much money does Kin and Carta make?

Kin and Carta has a market capitalization of £392.01 million and generates £174.43 million in revenue each year.

How many employees does Kin and Carta have?

Kin and Carta employs 1,367 workers across the globe.

What is Kin and Carta's official website?

The official website for Kin and Carta is www.st-ives.co.uk.

How can I contact Kin and Carta?

The company can be reached via phone at 44 20 7928 8844.

This page was last updated on 5/21/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.